{
  "ticker": "IMNM",
  "company_name": "Immunome, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06823167",
      "title": "A Phase 1 Study of IM-1021 in Participants With Advanced Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Solid Malignancies, Hematologic Malignancies",
      "start_date": "2025-02-26",
      "completion_date": "2029-02",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT06855264",
      "title": "A Cardiac Liability Study of Varegacestat in Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2025-02-24",
      "completion_date": "2025-05-06",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT06845852",
      "title": "A Phase 1 Mass Balance Study of Varegacestat",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2025-02-25",
      "completion_date": "2025-03-26",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT04871282",
      "title": "A Study of AL102 in Patients With Progressing Desmoid Tumors",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Desmoid, Desmoid Tumor",
      "start_date": "2021-03-30",
      "completion_date": "2026-10",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT06677996",
      "title": "A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2024-11-11",
      "completion_date": "2025-05-07",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT06841315",
      "title": "A Varegacestat Hepatic Impairment Study",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer, Hepatic Impairment (HI)",
      "start_date": "2025-03-07",
      "completion_date": "2026-02",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    },
    {
      "nct_id": "NCT05429021",
      "title": "IMM-BCP-01 in Mild to Moderate COVID-19",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "SARS-CoV2 Infection, COVID-19",
      "start_date": "2022-06-03",
      "completion_date": "2023-01-06",
      "enrollment": 0,
      "sponsor": "Immunome, Inc."
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 6,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "RECRUITING": 1,
      "COMPLETED": 3,
      "ACTIVE_NOT_RECRUITING": 2,
      "TERMINATED": 1
    },
    "active_trials": 3,
    "completed_trials": 3,
    "conditions": [
      "Desmoid, Desmoid Tumor",
      "Healthy Volunteer",
      "Healthy Volunteer, Hepatic Impairment (HI)",
      "SARS-CoV2 Infection, COVID-19",
      "Solid Malignancies, Hematologic Malignancies"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:36:07.535028",
    "search_query": "Immunome, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Immunome,+Inc."
  }
}